1 March 2022 - The Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Stephen J. Ubl released the following statement following President Biden’s State of the Union address:

“Tonight, President Biden outlined the challenges and opportunities we face as a nation. As we’ve seen throughout the pandemic, America’s biopharmaceutical industry is a leader in innovation and tackling big problems. We will continue to do our part to help end the pandemic and build a stronger, more equitable and affordable health care system. Innovative treatments can only improve lives if they are accessible and affordable, yet we know many patients face out-of-pocket costs they can’t afford and harmful barriers that stand between them and the care they need."

Read Pharmaceutical Research and Manufacturers of America press release